<DOC>
	<DOCNO>NCT00683579</DOCNO>
	<brief_summary>ATN 071 prospective cohort study compare neurocognitive function four group youth , age 18-24 : Two group CD4+ T cell 350 cells/mm3 HIV RNA &gt; 1,000 copies/ml , one initiate HAART ( Group 1 ) initiating treatment ( Group 2 ) ; two group CD4+ T cell &lt; 350 cells/mm3 , one initiating treatment ( Group 3 ) initiating treatment ( Group 4 ) . Groups 2 3 represent standard care . Group 1 portion group 2 co-enrolled ATN 061 randomly assign group protocol .</brief_summary>
	<brief_title>Neurocognitive Assessment Youth Initiating HAART</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Groups 1 2 ( If coenrolling ATN 061 ) HIV positive participant age 18 year 0 day 24 year 364 day ( low age limit study drive restriction ATZ use age 18 great ) ; Groups 1 2 : CD4+ T cell 350 cells/mm3 HIV RNA &gt; 1,000 copies/ml , determine two consecutive measure within 6 month entry second measure collect preentry ATN 061 ; Infected HIV age nine via behavioral mean ; Naïve ART except HAART PMTCT six month less least six month since time exposure ; HIV genotype without major resistance mutation recommend ATVr base HAART regimens ; Able provide write informed consent determine local Institutional Review Boards ; Fluent English Spanish . Group 2 , enrol ATN 071 ATN 061 CD4+ T cell 350 cells/mm3 HIV RNA &gt; 1,000 copies/ml , determine recent laboratory evaluation available within 4 month prior entry ; Not prescribed HAART accord DHHS guideline . Groups 3 4 : HIV positive participant age 18 year 0 day 24 year 364 day ; Infected HIV age nine via behavioral mean ; Naïve ART except HAART PMTCT six month less least six month since time exposure ; Able provide write informed consent determine local Institutional Review Boards ; Fluent English Spanish . CD4+ T cell &lt; 350 cells/mm3 , determine recent laboratory evaluation available within 4 month prior entry . Group 3 ONLY : Participant initiate HAART . Group 4 ONLY : HAART prescribe due either participant 's refusal initiate HAART provider 's concern participant 's predicted inability adhere regimen . Groups 1 2 : For Groups 1 2 : history AIDSdefining illness ; Active drug alcohol use dependence , opinion site personnel , would interfere meeting study requirement ; History cognitive motor impairment due nonHIVrelated condition ( example , prematurity , cerebral palsy , close head injury , CNS cancer cranial irradiation , etc . ) psychosis . Youth diagnose learn disability attention deficit hyperactivity disorder allow study ; Enrollment youth chronic acute medical condition HIV could potentially impact upon neurocognitive functioning require protocol chair approval . Pregnancy time study include entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>HAART</keyword>
	<keyword>DHHS guideline</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>